2 not yet recruiting. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow TUDCA (Tauroursodeoxycholic Acid) Supplementation: new trials by email Literature Review of TUDCA (Tauroursodeoxycholic Acid) Supplementation trials Research Report on TUDCA (Tauroursodeoxycholic Acid) Supplementation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study TUDCA (Tauroursodeoxycholic Acid) Supplementation, Immune checkpoint inhibitor (ICI) - Hepatocellular Carcinoma | Phase 2 | Not yet recruiting | Tongji Hospital | 300 | 2025-07-30 | 2025-07-15 |
| Effect of Oral Supplements for Influenza Vaccine Response ARA (Arachidonic Acid) Supplementation, TUDCA (Tauroursodeoxycholic Acid) Supplementation, Placebo Supplementation - Influenza Vaccine Response | Not applicable | Not yet recruiting | Tsinghua University | 45 | 2025-02-01 | 2025-02-14 |
Tongji Hospital (1) · Tsinghua University (1)
China (2)
PMID 31757001, PMID 34071550, PMID 34585527, PMID 35365570, PMID 35928688, PMID 35996998, PMID 36633259, PMID 38058259, PMID 38664391, PMID 39340066, PMID 39915447